These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21220309)

  • 21. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis.
    Ludwig R; Kretschmer M; Caspar G; Bojunga J; Oldenburg A; Schumm-Draeger P; Stegmüller M; von Minckwitz G; Usadel KH; Kusterer K
    Immunology; 1999 Sep; 98(1):111-5. PubMed ID: 10469241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
    Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
    J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic regulatory T cells subvert effector T cell function in inflamed islets to halt autoimmune diabetes.
    Mahne AE; Klementowicz JE; Chou A; Nguyen V; Tang Q
    J Immunol; 2015 Apr; 194(7):3147-55. PubMed ID: 25732730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
    Muir A; Peck A; Clare-Salzler M; Song YH; Cornelius J; Luchetta R; Krischer J; Maclaren N
    J Clin Invest; 1995 Feb; 95(2):628-34. PubMed ID: 7860747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
    Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice.
    Levisetti MG; Suri A; Vidavsky I; Gross ML; Kanagawa O; Unanue ER
    Int Immunol; 2003 Dec; 15(12):1473-83. PubMed ID: 14645156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets.
    Hu C; Ding H; Li Y; Pearson JA; Zhang X; Flavell RA; Wong FS; Wen L
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11318-23. PubMed ID: 26305961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes.
    Fossati G; Cooke A; Papafio RQ; Haskins K; Stockinger B
    J Exp Med; 1999 Aug; 190(4):577-83. PubMed ID: 10449528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
    Pakala SV; Chivetta M; Kelly CB; Katz JD
    J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.